Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 266

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 266
---
 — |
| Total                                                  |     |             | 3,247 |    |     | $                | 200.00 |    |     |               | 20,704 |

| (1) | Includes 3 shares subject to outstanding                                                                                         
 stock options under the 2016 Plan that were outstanding on December 31, 2023 (presented on an as-converted basis). No new awards 
 may be granted under the 2016 Plan.                                                                                              |

| (2) | Reflects the weighted-average                                                                                                  
 exercise price of the $200.00 outstanding stock options under the 2024 Plan and 2016 Plan, presented on an as-converted basis. |

158 On February 8, 2024, the stockholders approved the 2024 Plan and 2024 ESPP, with an initial reserve of 2,586 and 255 shares of common stock, respectively. The 2024 Plan and 2024 ESPP became effective on February 14, 2024 in connection with the closing of the Business Combination. At a special meeting of stockholders on April 30, 2024, the stockholders approved an increase in the number of shares available for issuance under the 2024 Plan and the number of shares that may be issued pursuant to incentive stock options, by an additional 1,000 shares each. At a special meeting of stockholders on November 11, 2024, the stockholders approved an increase in the number of shares available for issuance under the 2024 Plan and the number of shares that may be issued pursuant to incentive stock options, by an additional 10,424 shares each. As of September 30, 2025, no awards have been granted under the 2024 ESPP. No new awards may be granted under the 2016 Plan, but all outstanding awards under the 2016 Plan continue to be governed by their existing terms. The 2024 Plan has an evergreen provision that allows for an annual increase in the number of shares available for issuance under the 2024 Plan to be added on the first day of January, starting with January 1, 2025, in an amount equal to the lesser of (i) 5% of the fully diluted shares of our common stock on the immediately preceding December 31 or (ii) such number of shares as determined by our board in each case subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization